Weight Loss: A study has found a link between obesity and weekly usage of semaglutide. Semaglutide is widely used for the treatment of diabetes. It acts like human glucagon-like peptide-1 in that it increases insulin secretion. "In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight," the study, which has been published in The New England Journal of Medicine, says.

from Times of India https://timesofindia.indiatimes.com/life-style/health-fitness/weight-loss/a-study-says-weekly-jab-for-weight-loss-might-be-a-possibility-in-near-future/articleshow/89451350.cms